SCHEMBL622244

SCHEMBL622244

OC(C1CO1)C1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4306422 1.00
SCHEMBL12517981 0.81
SCHEMBL11781214 0.79 NOS2 (0.32)
Dianhydrogalactitol SCHEMBL4307933 0.77 THRB (0.30)
Dianhydrogalactitol SCHEMBL8375579 0.77 THRB (0.30)
Dianhydrogalactitol SCHEMBL4304281 0.77 THRB (0.30)
Dianhydrogalactitol SCHEMBL16387832 0.77 THRB (0.30)
Dianhydrogalactitol SCHEMBL4306431 0.77 THRB (0.30)
Dianhydrogalactitol SCHEMBL17264073 0.77 THRB (0.30)
Dianhydrogalactitol SCHEMBL21761430 0.77 THRB (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106174727-B Bra fixing ring 袁惠芬 2017-12-01 CN disclosed
US-9738596-B2 Contrast agents GE HEALTHCARE AS (NO) 2017-08-22 US disclosed
US-9738596-B2 Contrast agents GE HEALTHCARE AS (NO) 2017-08-22 US disclosed
US-9738596-B2 Contrast agents GE HEALTHCARE AS (NO) 2017-08-22 US disclosed
CN-106174727-A Bra fixing ring and preparation method thereof 袁惠芬 2016-12-07 CN disclosed
US-9416218-B2 Methods for producing thermosetting epoxy resins CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2016-08-16 US disclosed
US-9416218-B2 Methods for producing thermosetting epoxy resins CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2016-08-16 US disclosed
US-20150191422-A1 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2015-07-09 US disclosed
US-20150191422-A1 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2015-07-09 US disclosed
US-20150191422-A1 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2015-07-09 US disclosed
EP-2178568-A2 CONTRAST AGENTS GE Healthcare AS (NO) 2010-04-28 EP disclosed
WO-2009106552-A2 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2009-09-03 WO disclosed
WO-2009008734-A2 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2009-01-15 WO disclosed
WO-2009008734-A2 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2009-01-15 WO disclosed
EP-1981842-A2 SULFONAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF sanofi-aventis (FR) 2008-10-22 EP disclosed
WO-2007088276-A2 SULFONAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2007-08-09 WO disclosed
EP-0804464-A1 AROMATIC HETEROCYCLIC DERIVATIVES AS ENZYME INHIBITORS CORVAS INTERNATIONAL, INC. (US) 1997-11-05 EP disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
WO-1996018644-A1 AROMATIC HETEROCYCLIC DERIVATIVES AS ENZYME INHIBITORS CORVAS INTERNATIONAL, INC. (US) 1996-06-20 WO disclosed